Skip to content
Back to Guavy Wire
Stocks

Amgen Opens New Science and Innovation Center in Hyderabad

Instruments
AMGN
Share

Amgen, a biotechnology company, has announced plans to open a new Science and Innovation Center at Genome Valley in Hyderabad, India. The center will join Amgen's global Research and Development network, which consists of seven research laboratories.

The center is expected to be operational by 2027 and will bring together scientists and technologists from various fields, including discovery chemistry, drug metabolism & pharmacokinetics, and precision medicine.

According to Jay Bradner, Executive Vice President of Research and Development, Artificial Intelligence and Data at Amgen, the new center in Genome Valley will expand the way experimental science is integrated with data and technology across the company's global research capabilities.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc